Sharpless Norman 4
4 · G1 Therapeutics, Inc. · Filed Jun 16, 2023
Insider Transaction Report
Form 4
Sharpless Norman
Director
Transactions
- Award
Common Stock
2023-06-15+10,000→ 10,000 total - Award
Stock Options (Right to Buy)
2023-06-15+30,000→ 30,000 totalExercise: $2.83Exp: 2033-06-15→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award that vests in its entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director. The Reporting Person has elected to defer vesting of these shares pursuant to the G1 Therapeutics, Inc. Deferred Compensation Plan for Non-Employee Directors. The RSUs will vest upon termination of the Reporting Person's service as a Director on the Company's Board.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock.
- [F3]The shares underlying this option will vest in their entirety twelve months after June 15, 2023, subject to the Reporting Person's continued service as a director.